The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been associated with Parkinson's disease, and its inhibition opens potential new therapeutic options. Among the drug inhibitors of both wild-type and mutant LRRK2 forms is the 2-arylmethyloxy-5-subtitutent-N-arylbenzamide GSK257815...

Descripción completa

Detalles Bibliográficos
Autores principales: Saez-Atienzar, S, Bonet-Ponce, L, Blesa, J R, Romero, F J, Murphy, M P, Jordan, J, Galindo, M F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454299/
https://www.ncbi.nlm.nih.gov/pubmed/25118928
http://dx.doi.org/10.1038/cddis.2014.320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454299/
https://www.ncbi.nlm.nih.gov/pubmed/25118928
http://dx.doi.org/10.1038/cddis.2014.320

Ejemplares similares